Amanote Research
Register
Sign In
Aromatase Inhibitors: A Dose-Response Effect?
Endocrine-Related Cancer
- United Kingdom
doi 10.1677/erc.0.0060245
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Date
June 1, 1999
Authors
I E Smith
Publisher
Bioscientifica
Related search
The Effect of Third-Generation Aromatase Inhibitors on Aromatase Avtivity in Visceral Adipose Tissue
Regulatory Mechanisms in Biosystems
Molecular Docking of Aromatase Inhibitors
Molecules
Organic Chemistry
Molecular Medicine
Analytical Chemistry
Theoretical Chemistry
Pharmaceutical Science
Medicine
Drug Discovery
Chemistry
Physical
Bone Loss and the Aromatase Inhibitors
British Journal of Cancer
Cancer Research
Oncology
Carryover Effects of Aromatase Inhibitors in Prevention
The Lancet
Medicine
Functional Genetic Polymorphisms in the Aromatase Gene CYP19 Vary the Response of Breast Cancer Patients to Neoadjuvant Therapy With Aromatase Inhibitors
Breast Diseases
Oncology
Surgery
Use of Aromatase Inhibitors in Breast Carcinoma
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Molecular Action and Clinical Relevance of Aromatase Inhibitors
Oncologist
Cancer Research
Medicine
Oncology
Aromatase and Its Inhibitors: New Biology and Clinical Perspectives
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Treatment of Hormone Positive Uterine Leiomyosarcoma With Aromatase Inhibitors
Clinical Sarcoma Research
Oncology
